Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Poseida Therapeutics, Inc. | 7,013,918 | reported | 14 Jul 2020 | tx 10+9,218,125−11,457,593 |
| TriSalus Life Sciences, Inc. | 554,681 | reported | 12 Jun 2025 | tx 11+519,845 |
| Novan, Inc. | 20,000 | reported | 04 Jun 2018 | tx 3+68,498 |
| MPM ACQUISITION CORP | 0 | reported | 15 Aug 2022 | tx 8+81,000−15,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 44,884 | 5.18 USD | |
| 18 Feb 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,817 | 0.00 USD | |
| 27 Jan 2025 | PURCHASE | TriSalus Life Sciences, Inc. | 15,000 | 5.31 USD | first after silence |
| 27 Jan 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 12,500 | 0.00 USD | |
| 28 Jan 2025 | PURCHASE | TriSalus Life Sciences, Inc. | 15,000 | 5.17 USD | |
| 27 Jan 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 75,000 | 0.00 USD | deriv |
| 12 Feb 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 34,144 | 0.00 USD | |
| 12 Feb 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 105,000 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 125,000 | 0.00 USD | deriv |
| 11 Aug 2023 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 62,500 | 0.00 USD | deriv |
| 15 Aug 2022 | TENDER | MPM ACQUISITION CORP | 5,500 | 10.00 USD | |
| 15 Aug 2022 | OTHER | MPM ACQUISITION CORP | 10,000 | 3.60 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | MPM ACQUISITION CORP | 5,500 | 0.00 USD | |
| 14 Jan 2022 | GRANT_AWARD | MPM ACQUISITION CORP | 10,000 | 0.00 USD | deriv |
| 22 Feb 2021 | GRANT_AWARD | MPM ACQUISITION CORP | 5,500 | — | |
| 22 Feb 2021 | GRANT_AWARD | MPM ACQUISITION CORP | 10,000 | 0.00 USD | deriv |
| 21 Jan 2021 | GRANT_AWARD | MPM ACQUISITION CORP | 20,000 | 0.00 USD | deriv |
| 10 Aug 2020 | GRANT_AWARD | MPM ACQUISITION CORP | 30,000 | 0.00 USD | deriv |
| 14 Jul 2020 | PURCHASE | Poseida Therapeutics, Inc. | 10,000 | 16.00 USD | |
| 14 Jul 2020 | CONVERSION | Poseida Therapeutics, Inc. | 315,098 | — | |
| 14 Jul 2020 | CONVERSION | Poseida Therapeutics, Inc. | 690,124 | — | |
| 14 Jul 2020 | CONVERSION | Poseida Therapeutics, Inc. | 7,013,918 | — | |
| 14 Jul 2020 | CONVERSION | Poseida Therapeutics, Inc. | 1,168,985 | — | |
| 14 Jul 2020 | CONVERSION | Poseida Therapeutics, Inc. | 392,927 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 27 Jan 2025.